CVSA Covista Inc. Common Shares

NYSE · Diversified Consumer Services · View on SEC EDGAR ↗
$134.92
Price · Aug 18, 2026
Fundamentals as of Aug 6, 2026

About Covista Inc. Common Shares Company overview from Wikipedia

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Read more

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.

History

DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.

In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.

In November 2013, DeVry Inc. was renamed DeVry Education Group.

Rebranding from DeVry Education Group to Adtalem Global Education

Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.

Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."

The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.

Acquisitions and divestitures

Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.

At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.

Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.

Operations

Campuses and enrollment

Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.

Leadership

Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.

Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.

Finances

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.

Controversies

Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.

Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.

For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.

As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.

In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.

A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.

In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.

In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.

In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

CVSA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$134.91
Market Cap
$4.59B
P/E (TTM)
19.2
EPS (TTM)
$7.04
Revenue (TTM)
$1.95B
Div Yield
ROE
17.8%
Debt/Equity
0.5
52W Range
$87 – $156

CVSA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $1.95B
6-point trend, +117.3%
2021-06-30 2026-06-30
EPS $7.04
6-point trend, +417.6%
2021-06-30 2026-06-30
Free Cash Flow $393M
6-point trend, +173.6%
2021-06-30 2026-06-30
Margins 12.9%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CVSA
Peer Median
P/E (TTM)
5-point trend, +216.5%
19.2
15.2
P/S (TTM)
5-point trend, +84.6%
2.3
1.8
P/B
5-point trend, +171.7%
3.2
3.6
EV / EBITDA
5-point trend, -55.4%
12.6
Price / FCF
5-point trend, +113.7%
11.7

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CVSA
Peer Median
Operating Margin
5-point trend, +238.3%
19.6%
Net Profit Margin
5-point trend, -43.8%
12.9%
11.7%
ROA
5-point trend, -10.0%
8.7%
7.9%
ROE
5-point trend, -16.3%
17.8%
15.8%
ROIC
5-point trend, +520.3%
14.1%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CVSA
Peer Median
Debt / Equity
5-point trend, -17.8%
0.5
Current Ratio
5-point trend, -17.9%
1.1
1.7
Quick Ratio
5-point trend, -5.9%
1.0

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CVSA
Peer Median
Revenue YoY
5-point trend, +41.4%
9.3%
Revenue CAGR 3Y
5-point trend, +41.4%
10.4%
Revenue CAGR 5Y
5-point trend, +41.4%
16.8%
EPS YoY
5-point trend, +9.5%
13.9%
Net Income YoY
5-point trend, -19.1%
6.1%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CVSA
Peer Median
EPS (Diluted)
5-point trend, +9.5%
$7.04

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CVSA
Peer Median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
Payout Ratio
5Y Div CAGR
Ex-dateAmount
Nov. 30, 2016$0.1800
June 1, 2016$0.1800
Dec. 2, 2015$0.1800
June 3, 2015$0.1800
Dec. 3, 2014$0.1800
June 4, 2014$0.1700
Dec. 4, 2013$0.1700
June 5, 2013$0.1700
Nov. 28, 2012$0.1700
June 19, 2012$0.1500
Dec. 6, 2011$0.1500
June 16, 2011$0.1200
Dec. 8, 2010$0.1200
June 11, 2010$0.1000
Dec. 9, 2009$0.1000
June 12, 2009$0.0800
Dec. 10, 2008$0.0800
June 17, 2008$0.0600
Dec. 12, 2007$0.0600
June 14, 2007$0.0500

CVSA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 4 40.0%
  • Buy 5 50.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

4 analysts · 2026-08-18
Median target $161.50 +19.7%
Mean target $159.50 +18.2%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.18%
Period EPS Actual EPS Est Surprise
June 30, 2026 $2.09 $1.93 0.16%
March 31, 2026 $1.98 $1.76 0.22%
Dec. 31, 2025 $2.43 $2.23 0.20%
Sept. 30, 2025 $1.75 $1.61 0.14%
June 30, 2025 $1.66 $1.56 0.10%
March 31, 2025 $1.92 $1.69 0.23%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CVSA $4.24B 17.7 9.3% 12.9% 17.8%
DUOL $8.18B 20.5 38.7% 39.9% 35.6% 72.2%
LAUR $4.81B 17.8 8.6% 16.6% 26.2%
GHC 16.5 2.5% 5.9% 6.5%
LOPE $4.56B 21.6 7.1% 19.5% 28.3%
LRN $3.58B 12.1 4.7% 13.4% 21.3% 37.8%
BFAM $5.64B 30.2 9.2% 6.6% 14.1% 23.8%
MH $2.62B 72.1 0.07% 1.7% 4.6% 80.9%
PRDO $1.83B 12.1 24.2% 18.9% 16.3%
STRA $1.84B 14.8 4.0% 10.0% 7.6%
UTI $1.77B 28.8 14.1% 7.5% 20.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for CVSA
Metric Trend 20262025202420232022202120202019
Revenue 5-point trend, +41.4% $1.95B $1.79B $1.58B $1.45B $1.38B · · ·
Cost of Revenue 5-point trend, +26.4% $834M $771M $699M $648M $660M · · ·
SG&A Expense 5-point trend, +29.0% $731M $672M $633M $586M $566M · · ·
Operating Expenses 5-point trend, +20.4% $1.57B $1.45B $1.37B $1.28B $1.31B · · ·
Operating Income 5-point trend, +399.5% $383M $342M $217M $168M $77M · · ·
Interest Expense 5-point trend, -64.9% $45M $52M $64M $63M $129M · · ·
Interest Income · · · · $4M · · ·
Other Non-op 5-point trend, +547.8% $7M $9M $11M $7M $1M · · ·
Pretax Income 5-point trend, +770.2% $345M $299M $164M $112M $-51M · · ·
Income Tax 5-point trend, +600.3% $78M $66M $26M $10M $-16M · · ·
Net Income 5-point trend, -19.1% $252M $237M $137M $93M $311M · · ·
EPS (Basic) 5-point trend, +11.7% $7.18 $6.39 $3.47 $2.08 $6.43 · · ·
EPS (Diluted) 5-point trend, +9.5% $7.04 $6.18 $3.39 $2.05 $6.43 · · ·
Shares (Basic) 5-point trend, -27.6% 35,045,000 37,085,000 39,413,000 44,781,000 48,388,000 · · ·
Shares (Diluted) 5-point trend, -26.2% 35,715,000 38,334,000 40,307,000 45,600,000 48,388,000 · · ·
EBITDA 5-point trend, +376.5% $383M $342M $217M $168M $80M · · ·
Balance Sheet 28
Annual Balance Sheet data for CVSA
Metric Trend 20262025202420232022202120202019
Cash & Equivalents 8-point trend, +503.9% $406M $200M $219M $272M $347M $275M $416M $67M
Short-term Investments · · · · · · · $9M
Receivables 7-point trend, +141.6% $167M $143M $124M $100M $79M $90M $69M ·
Prepaid Expense 8-point trend, +65.9% $75M $69M $70M $102M $128M $167M $97M $45M
Current Assets 8-point trend, +67.3% $652M $416M $418M $480M $557M $611M $681M $390M
PP&E (Net) 8-point trend, +7.3% $303M $256M $249M $245M $290M $302M $279M $282M
PP&E (Gross) 8-point trend, +13.3% $686M $598M $575M $583M $666M $663M $618M $605M
Accum. Depreciation 8-point trend, +18.5% $383M $342M $326M $339M $376M $362M $339M $323M
Goodwill 8-point trend, +40.0% $961M $961M $961M $961M $961M $960M $310M $687M
Intangibles 8-point trend, +157.7% $754M $765M $777M $812M $874M $924M $138M $293M
Other Non-current Assets 8-point trend, +66.2% $138M $129M $103M $81M $119M $118M $88M $83M
Total Assets 8-point trend, +26.0% $3.01B $2.75B $2.74B $2.81B $3.03B $3.66B $2.27B $2.39B
Accounts Payable 8-point trend, +296.6% $125M $105M $103M $82M $57M $65M $39M $31M
Accrued Liabilities 8-point trend, +5.4% $94M $77M $97M $106M $98M $135M $97M $90M
Current Liabilities 8-point trend, +96.2% $597M $508M $488M $431M $424M $497M $341M $304M
Capital Leases 8-point trend, +15.5% $208M $186M $168M $163M $177M $156M $194M $180M
Deferred Tax 8-point trend, +148.0% $62M $32M $30M $26M $26M $27M $25M $25M
Other Non-current Liabilities 8-point trend, -52.4% $42M $40M $39M $37M $74M $58M $81M $89M
Total Liabilities 8-point trend, +43.4% $1.57B $1.32B $1.37B $1.35B $1.54B $2.37B $959M $1.09B
Long-term Debt 8-point trend, +59.7% $663M $553M $649M $695M $839M $1.61B $287M $415M
Total Debt 5-point trend, -21.0% $663M $553M $649M $695M $839M · · ·
Common Stock 8-point trend, +5.2% $848.0K $839.0K $832.0K $822.0K $818.0K $817.0K $810.0K $806.0K
Retained Earnings 8-point trend, +49.0% $3.03B $2.78B $2.54B $2.40B $2.31B $1.96B $1.97B $2.03B
Treasury Stock 8-point trend, +112.6% $2.29B $2.01B $1.78B $1.51B $1.34B $1.22B $1.16B $1.08B
AOCI 8-point trend, +98.6% $-2M $-2M $-2M $-2M $-2M $-634.0K $-8M $-159M
Stockholders' Equity 8-point trend, +11.7% $1.45B $1.43B $1.37B $1.46B $1.49B $1.28B $1.31B $1.29B
Liabilities + Equity 8-point trend, +26.0% $3.01B $2.75B $2.74B $2.81B $3.03B $3.66B $2.27B $2.39B
Shares Outstanding 8-point trend, -35.7% 34,033,000 35,952,000 37,681,000 82,232,000 81,796,000 81,705,000 81,021,000 52,953,000
Cash Flow 16
Annual Cash Flow data for CVSA
Metric Trend 20262025202420232022202120202019
Stock-based Comp 5-point trend, +82.3% $41M $42M $26M $14M $23M · · ·
Deferred Tax 5-point trend, +600.7% $68M $18M $11M $-5M $-14M · · ·
Amort. of Intangibles 5-point trend, -88.5% $11M $11M $36M $61M $97M · · ·
Restructuring 5-point trend, -75.3% $6M $3M $2M $19M $26M · · ·
Operating Cash Flow 5-point trend, +4337.5% $470M $338M $296M $192M $11M · · ·
CapEx 5-point trend, +150.2% $78M $50M $49M $26M $31M · · ·
Investing Cash Flow 5-point trend, +84.8% $-84M $-42M $-48M $24M $-552M · · ·
Debt Issued 5-point trend, +18.5% $1.01B $10M $2M $0 $850M · · ·
Net Debt Issued 5-point trend, +148.8% $112M $-100M $-50M $-151M $-230M · · ·
Stock Repurchased 5-point trend, +99.9% $240M $213M $262M $123M $120M · · ·
Net Stock Activity 5-point trend, -99.9% $-240M $-213M $-262M $-123M $-120M · · ·
Financing Cash Flow 5-point trend, +57.6% $-180M $-316M $-302M $-289M $-424M · · ·
Net Change in Cash 5-point trend, +121.4% $207M $-20M $-54M $-73M $-966M · · ·
Taxes Paid 5-point trend, -85.5% $14M $33M $31M $12M $94M · · ·
Free Cash Flow 5-point trend, +2003.7% $393M $288M $247M $166M $-21M · · ·
Levered FCF 5-point trend, +436.5% $358M $247M $193M $109M $-106M · · ·
Profitability 7
Annual Profitability data for CVSA
Metric Trend 20262025202420232022202120202019
Operating Margin 5-point trend, +238.3% 19.6% 19.1% 13.7% 11.6% 5.8% · · ·
Net Margin 5-point trend, -43.8% 12.9% 13.3% 8.6% 6.4% 22.9% · · ·
Pretax Margin 5-point trend, +643.4% 17.7% 16.7% 10.3% 7.7% -3.2% · · ·
EBITDA Margin 5-point trend, +238.3% 19.6% 19.1% 13.7% 11.6% 5.8% · · ·
ROA 5-point trend, -10.0% 8.7% 8.6% 4.9% 3.3% 9.7% · · ·
ROE 5-point trend, -16.3% 17.8% 16.5% 10.2% 6.3% 21.3% · · ·
ROIC 5-point trend, +520.3% 14.1% 13.4% 9.0% 7.1% 2.3% · · ·
Liquidity & Solvency 5
Annual Liquidity & Solvency data for CVSA
Metric Trend 20262025202420232022202120202019
Current Ratio 5-point trend, -17.9% 1.1 0.8 0.9 1.1 1.3 · · ·
Quick Ratio 5-point trend, -5.9% 1.0 0.7 0.7 0.9 1.0 · · ·
Debt / Equity 5-point trend, -17.8% 0.5 0.4 0.5 0.5 0.6 · · ·
LT Debt / Equity 5-point trend, -18.4% 0.5 0.4 0.5 0.5 0.6 · · ·
Interest Coverage 5-point trend, +1256.4% 8.4 6.5 3.4 2.7 0.6 · · ·
Efficiency 2
Annual Efficiency data for CVSA
Metric Trend 20262025202420232022202120202019
Asset Turnover 5-point trend, +60.0% 0.7 0.7 0.6 0.5 0.4 · · ·
Receivables Turnover 5-point trend, -21.6% 12.6 13.4 14.1 16.2 16.1 · · ·
Per Share 5
Annual Per Share data for CVSA
Metric Trend 20262025202420232022202120202019
Book Value / Share 5-point trend, +27.6% $42.49 $39.88 $36.33 $34.44 $33.31 · · ·
Revenue / Share 5-point trend, +90.9% $54.71 $46.65 $39.31 $31.82 $28.67 · · ·
Cash Flow / Share 5-point trend, +6014.9% $13.17 $8.81 $7.34 $4.45 $0.22 · · ·
Cash / Share 5-point trend, +55.4% $11.94 $5.55 $5.82 $6.47 $7.68 · · ·
EPS (TTM) 5-point trend, +9.5% $7.04 $6.18 $3.39 $2.05 $6.43 · · ·
Growth Rates 9
Annual Growth Rates data for CVSA
Metric Trend 20262025202420232022202120202019
Revenue YoY 5-point trend, -82.7% 9.3% 12.8% 9.2% 5.0% 53.7% · · ·
Revenue CAGR 3Y 4-point trend, -44.3% 10.4% 9.0% 20.8% 18.8% · · · ·
Revenue CAGR 5Y 2-point trend, +7.6% 16.8% 15.6% · · · · · ·
EPS YoY 5-point trend, -96.3% 13.9% 82.3% 65.4% -68.1% 372.8% · · ·
EPS CAGR 3Y 3-point trend, +42.9% 50.9% -1.3% 35.6% · · · · ·
EPS CAGR 5Y 38.9% · · · · · · ·
Net Income YoY 5-point trend, -98.2% 6.1% 73.3% 46.5% -70.0% 344.1% · · ·
Net Income CAGR 3Y 3-point trend, +56.6% 39.2% -8.6% 25.0% · · · · ·
Net Income CAGR 5Y 29.1% · · · · · · ·
Valuation (TTM) 13
Annual Valuation (TTM) data for CVSA
Metric Trend 20262025202420232022202120202019
Revenue TTM 5-point trend, +41.4% $1.95B $1.79B $1.58B $1.45B $1.38B · · ·
Net Income TTM 5-point trend, -19.1% $252M $237M $137M $93M $311M · · ·
Market Cap 5-point trend, +161.1% $4.24B $4.57B $2.57B $1.45B $1.63B · · ·
Enterprise Value 5-point trend, +112.5% $4.50B $4.93B $3.00B $1.87B $2.12B · · ·
P/E 5-point trend, +216.5% 17.7 20.6 20.1 16.8 5.6 · · ·
P/S 5-point trend, +84.6% 2.2 2.6 1.6 1.0 1.2 · · ·
P/B 5-point trend, +171.7% 2.9 3.2 1.9 1.0 1.1 · · ·
P / Cash Flow 5-point trend, -94.2% 9.0 13.5 8.7 7.2 155.9 · · ·
P / FCF 5-point trend, +113.7% 10.8 15.9 10.4 8.8 -78.8 · · ·
EV / EBITDA 5-point trend, -55.4% 11.7 14.4 13.8 11.1 26.3 · · ·
EV / FCF 5-point trend, +111.2% 11.5 17.1 12.2 11.3 -102.6 · · ·
EV / Revenue 5-point trend, +50.3% 2.3 2.8 1.9 1.3 1.5 · · ·
Earnings Yield 5-point trend, -68.4% 5.7% 4.9% 5.0% 6.0% 17.9% · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2026-06-302025-06-302024-06-302023-06-302022-12-31
Revenue $1.95B$1.79B$1.58B$1.45B
Operating Margin % 19.6%19.1%13.7%11.6%
Net Income $252M$237M$137M$93M
Diluted EPS $7.04$6.18$3.39$2.05
Balance Sheet
2026-06-302025-06-302024-06-302023-06-302022-12-31
Debt / Equity 0.50.40.50.5
Current Ratio 1.10.80.91.1
Quick Ratio 1.00.70.70.9
Cash Flow
2026-06-302025-06-302024-06-302023-06-302022-12-31
Free Cash Flow $393M$288M$247M$166M

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 402 filers · $3.0B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
61 (+15 vs prior Q) 30 (-23 vs prior Q) 137 (+3 vs prior Q) 121 (-7 vs prior Q) +4.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $418,746,711 4,047,035 14.07% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $297,558,184 2,386,958 10.00% Shares
FMR LLC $280,021,015 2,246,278 9.41% Shares
DIMENSIONAL FUND ADVISORS LP $208,992,241 1,676,499 7.02% Shares
VANGUARD CAPITAL MANAGEMENT LLC $183,742,358 1,473,948 6.17% Shares
STATE STREET CORP $173,212,203 1,389,477 5.82% Shares
Capital World Investors $132,593,736 1,063,643 4.46% Shares
GEODE CAPITAL MANAGEMENT, LLC $95,719,361 767,678 3.22% Shares
WELLINGTON MANAGEMENT GROUP LLP $87,910,731 705,204 2.95% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $78,581,301 630,365 2.64% Shares
Alyeska Investment Group, L.P. $68,807,458 551,961 2.31% Shares
Fisher Asset Management, LLC $63,050,035 505,776 2.12% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60,245,186 483,276 2.02% Shares
NEUMEIER POMA INVESTMENT COUNSEL LLC $44,010,839 353,047 1.48% Shares
FRONTIER CAPITAL MANAGEMENT CO LLC $37,728,848 302,654 1.27% Shares
TWO SIGMA INVESTMENTS, LP $32,342,164 259,443 1.09% Shares
VANGUARD FIDUCIARY TRUST CO $30,437,360 244,163 1.02% Shares
PRINCIPAL FINANCIAL GROUP INC $26,065,659 209,094 0.88% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $23,386,341 187,601 0.79% Shares
SG Capital Management LLC $22,238,845 178,396 0.75% Shares
TWO SIGMA ADVISERS, LP $19,876,587 192,100 0.67% Shares
ALGERT GLOBAL LLC $19,323,048 155,006 0.65% Shares
MORGAN STANLEY $18,731,418 150,260 0.63% Shares
Public Sector Pension Investment Board $17,393,810 139,530 0.58% Shares
Corient Private Wealth LP $16,950,396 135,973 0.57% Shares
WESTPORT ASSET MANAGEMENT INC $15,677,117 125,759 0.53% Shares
Bank of New York Mellon Corp $15,262,248 122,431 0.51% Shares
PRUDENTIAL FINANCIAL INC $14,091,816 113,042 0.47% Shares
MACKENZIE FINANCIAL CORP $13,510,152 108,376 0.45% Shares
Qube Research & Technologies Ltd $12,647,380 101,455 0.43% Shares
BANK OF AMERICA CORP /DE/ $12,502,650 100,294 0.42% Shares
RHUMBLINE ADVISERS $10,647,181 85,410 0.36% Shares
MILLENNIUM MANAGEMENT LLC $9,671,247 77,581 0.33% Shares
Foresight Group Ltd Liability Partnership $9,636,366 77,264 0.32% Shares
AMERICAN CENTURY COMPANIES INC $9,436,388 75,697 0.32% Shares
ALLIANCEBERNSTEIN L.P. $8,879,782 77,048 0.30% Shares
BlackRock, Inc. $8,832,036 70,849 0.30% Shares
LAZARD ASSET MANAGEMENT LLC $8,696,157 69,759 0.29% Shares
Swiss National Bank $8,638,938 69,300 0.29% Shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $8,557,000 68,639 0.29% Shares
Universal- Beteiligungs- und Servicegesellschaft mbH $8,419,536 67,540 0.28% Shares
Hillsdale Investment Management Inc. $8,077,968 64,800 0.27% Shares
BNP PARIBAS FINANCIAL MARKETS $8,030,847 64,422 0.27% Shares
RENAISSANCE GROUP LLC $7,608,748 61,036 0.26% Shares
AMERIPRISE FINANCIAL INC $7,563,622 60,674 0.25% Shares
GOLDMAN SACHS GROUP INC $7,528,716 60,394 0.25% Shares
Allianz Asset Management GmbH $7,053,013 56,578 0.24% Shares
LONESTAR CAPITAL MANAGEMENT LLC $6,856,300 55,000 0.23% Shares
Legal & General Group Plc $6,503,387 52,169 0.22% Shares
Phocas Financial Corp. $6,345,443 50,902 0.21% Shares
WEDGE CAPITAL MANAGEMENT L L P/NC $6,335,869 54,975 0.21% Shares
FIRST TRUST ADVISORS LP $6,152,968 49,358 0.21% Shares
ExodusPoint Capital Management, LP $5,906,141 47,378 0.20% Shares
KESTREL INVESTMENT MANAGEMENT CORP $5,896,418 47,300 0.20% Shares
LEUTHOLD GROUP, LLC $5,622,914 45,106 0.19% Shares
ENVESTNET ASSET MANAGEMENT INC $5,482,297 43,978 0.18% Shares
Connor, Clark & Lunn Investment Management Ltd. $5,313,757 42,626 0.18% Shares
LGT Fund Management Co Ltd. $4,992,633 40,050 0.17% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $4,840,500 42,000 0.16% Shares
Trexquant Investment LP $4,814,120 38,618 0.16% Shares
FARLEY CAPITAL L.P. $4,644,333 37,256 0.16% Shares
SEI INVESTMENTS CO $4,541,490 36,431 0.15% Shares
CHURCHILL MANAGEMENT Corp $4,474,806 35,171 0.15% Shares
INTECH INVESTMENT MANAGEMENT LLC $4,270,726 34,259 0.14% Shares
VANGUARD ASSET MANAGEMENT, Ltd $3,909,088 31,358 0.13% Shares
HSBC HOLDINGS PLC $3,726,330 29,614 0.13% Shares
PANAGORA ASSET MANAGEMENT INC $3,568,268 28,624 0.12% Shares
Smith Group Asset Management, LLC $3,304,113 26,505 0.11% Shares
OP Asset Management Ltd $3,295,387 26,435 0.11% Shares
Horizon Investments, LLC $3,257,730 21,000 0.11% Shares
Atom Investors LP $3,165,242 25,391 0.11% Shares
FORMULA GROWTH LTD $3,140,933 25,196 0.11% Shares
STATE OF WISCONSIN INVESTMENT BOARD $3,064,891 24,586 0.10% Shares
BARCLAYS PLC $2,926,019 23,472 0.10% Shares
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $2,840,627 22,787 0.10% Shares
NewEdge Wealth, LLC $2,790,514 22,385 0.09% Shares
Elo Mutual Pension Insurance Co $2,724,943 21,859 0.09% Shares
RENAISSANCE TECHNOLOGIES LLC $2,717,588 21,800 0.09% Shares
NEW YORK STATE COMMON RETIREMENT FUND $2,695,523 21,623 0.09% Shares
MetLife Investment Management, LLC $2,499,807 20,053 0.08% Shares
Global Alpha Capital Management Ltd. $2,430,995 19,501 0.08% Shares
FIFTH THIRD BANCORP $2,403,502 19,280 0.08% Shares
ROYCE & ASSOCIATES LP $2,376,768 19,066 0.08% Shares
Boston Partners $2,293,116 18,393 0.08% Shares
Quantinno Capital Management LP $2,288,134 18,355 0.08% Shares
Grantham, Mayo, Van Otterloo & Co. LLC $2,256,097 18,098 0.08% Shares
LGT CAPITAL PARTNERS LTD. $2,206,482 17,700 0.07% Shares
IEQ CAPITAL, LLC $2,199,751 17,646 0.07% Shares
VIRGINIA RETIREMENT SYSTEMS ET Al $2,141,829 20,700 0.07% Shares
Bridgewater Associates, LP $2,138,044 17,151 0.07% Shares
CITIGROUP INC $2,106,879 16,901 0.07% Shares
CITADEL ADVISORS LLC $2,106,754 16,900 0.07% Call option
Banque Cantonale Vaudoise $2,082,000 16,700 0.07% Shares
Mariner, LLC $2,075,942 16,653 0.07% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $2,064,120 16,558 0.07% Shares
Illinois Municipal Retirement Fund $2,054,147 16,478 0.07% Shares
Gotham Asset Management, LLC $2,014,256 16,158 0.07% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,982,094 15,900 0.07% Call option
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $1,977,731 15,865 0.07% Shares
Zurcher Kantonalbank (Zurich Cantonalbank) $1,902,312 15,260 0.06% Shares

Company insiders 111 insiders · 46 officers · 24 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Daniel Hamburger President and CEO Aug. 31, 2015 S 142,136 0 0 $0
Michael O Randolfi SVP, Chief Financial Officer Aug. 28, 2020 F 84,391 0 0 $0
Timothy J Wiggins SVP & Chief Financial Officer Feb. 25, 2016 S 44,939 0 0 $0
Richard Gunst Chief Financial Officer Feb. 1, 2012 M 9,356 0 0 $0
Amelia Manning President, Chamberlain Univ. July 15, 2026 A 4,317 0 0 $0
Karen Sue Cox President, Chamberlain Univ. May 8, 2026 S 31,596 0 1 $-249,000
Scott Liles President, Medical and Vet April 15, 2026 F 13,103 0 0 $0
Evan Trent President, Adtalem Elevate Nov. 13, 2025 F 24,134 0 0 $0
Thiago Aguiar Sayao Group President, Business &Law Feb. 28, 2020 S 1,830 0 0 $0
Carlos Filgueiras Group President, Tech/Business Feb. 13, 2019 S 11,775 0 0 $0
Donna M Loraine President, Carrington Colleges Nov. 6, 2018 M 6,701 0 0 $0
Susan Groenwald President, Chamberlain Feb. 9, 2018 M 34,402 0 0 $0
John P Roselli President, Becker Professional Sept. 1, 2017 S 13,730 0 0 $0
Eric P. Dirst President, ATGE Shared Ops Aug. 31, 2017 S 14,800 0 0 $0
Robert A Paul President, DeVry University Aug. 25, 2017 M 28,426 0 0 $0
Steven Riehs President, Med, Prof & Online Sept. 2, 2016 M 28,062 0 0 $0
Jeffrey Richard Akens President, Carrington College Aug. 29, 2015 F 6,752 0 0 $0
Christopher Caywood President, Online Services March 1, 2013 F 7,378 0 0 $0
Andrew A Jeon President, DeVry Medical Int'l Nov. 2, 2012 F 5,655 0 0 $0
William B. Hughson President, Medical & Aug. 29, 2012 A 2,143 0 0 $0
Manjunath Gangadharan VP, Chief Accounting Officer May 18, 2026 F 5,271 0 1 $-128,072
Michael Betz Pres. Walden University & CDO Nov. 13, 2025 F 33,286 0 0 $0
Maurice Herrera SVP - Chief Marketing Officer Nov. 13, 2025 F 20,584 0 0 $0
Megan Noel Chief Corp. Affairs Officer Nov. 12, 2025 A 2,226 0 0 $0
Sara Hill CHRO Nov. 12, 2025 A 10,276 0 0 $0
Blake Simpson SVP, Chief Comms & CA Officer Dec. 5, 2024 F 8,795 0 0 $0
Steven Tom SVP Chief Customer Officer Nov. 13, 2024 A 13,255 0 0 $0
Cheryl James SVP, CHRO Feb. 28, 2024 F 17,485 0 0 $0
John W Danaher MD Pres. - Adtalem Med & Vet Aug. 25, 2023 F 38,718 0 0 $0
James Raymond Bartholomew SVP - Chamberlain University Aug. 26, 2022 F 6,418 0 0 $0
Holland Katherine Alice Boden Group Pres, Adtalem Health Aug. 30, 2021 F 32,148 0 0 $0
Fernando Lau SVP, Chief Marketing Officer Aug. 28, 2021 F 19,253 0 0 $0
Christopher C Nash SVP, Chief Information Officer Aug. 28, 2021 F 25,741 0 0 $0
Donna Jennings SVP, Human Resources Aug. 28, 2021 F 30,898 0 0 $0
Chaka M Patterson SVP and General Counsel Aug. 28, 2020 F 5,202 0 0 $0
Mehul R Patel Group Pres, Financial Services Nov. 7, 2019 F 11,258 0 0 $0
Kathleen Carroll Vice President, Controller Aug. 28, 2019 A 5,497 0 0 $0
Lisa M Sodeika SVP, Corporate Affairs Aug. 28, 2019 A 24,151 0 0 $0
Patrick J Unzicker Principal Financial Officer Aug. 27, 2019 F 36,360 0 0 $0
Catherine C. Anderson SVP, Strategy & Innovation Aug. 26, 2019 F 6,025 0 0 $0
Gena L Ashe SVP, CLO and Secretary Aug. 23, 2017 A 4,420 0 0 $0
Gregory S Davis SVP and General Counsel Sept. 1, 2016 S 22,433 0 0 $0
Adriano Allegrini VP, Strategy and Bus. Develop. Aug. 29, 2015 F 7,004 0 0 $0
Sharon Thomas Parrott SVP, Gov. & Regulatory Affairs Nov. 5, 2014 A 5,610 0 0 $0
David J Pauldine Executive Vice President & April 25, 2014 M 30,242 0 0 $0
Thomas C Shepherd Executive Vice President and May 27, 2011 M 0 0 0 $0
Michael W Malafronte Director March 11, 2026 P 25,395 5 0 $3,844,716
William V Krehbiel Director Nov. 13, 2025 F 16,303 0 0 $0
Betty M. Vandenbosch Director Nov. 13, 2025 F 2,584 0 0 $0
Kenneth J Phelan Director Nov. 13, 2025 F 19,836 1 0 $49,931

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
International Value Advisers, LLC, Charles de Vaulx ×18 filings Aug. 7, 2020 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 79 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
PSCD · Invesco Exchange-Traded Fund Trust … 1.82% 3,165 SH Aug. 8, 2026 Daily
PSL · Invesco Exchange-Traded Fund Trust 1.76% 10,579 SH Aug. 8, 2026 Daily
MYLD · Cambria ETF Trust 0.94% 2,418 NS April 30, 2026 N-PORT
XSHQ · Invesco Exchange-Traded Fund Trust … 0.91% 20,685 SH Aug. 8, 2026 Daily
RZG · Invesco Exchange-Traded Fund Trust 0.88% 8,705 SH Aug. 8, 2026 Daily
CGMM · Capital Group Equity ETF Trust I 0.80% 190,016 NS May 31, 2026 N-PORT
VUSE · ETF Series Solutions 0.53% 31,159 NS May 31, 2026 N-PORT
IJT · iShares Trust 0.47% 316,256 SH Aug. 8, 2026 Daily
CAFG · Pacer Funds Trust 0.47% 919 NS April 30, 2026 N-PORT
VIOG · VANGUARD ADMIRAL FUNDS 0.46% 40,509 SH Aug. 8, 2026 Daily
CALF · Pacer Funds Trust 0.46% 136,827 NS April 30, 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0.33% 29,825 NS April 30, 2026 N-PORT
QVMS · Invesco Exchange-Traded Fund Trust … 0.27% 4,982 SH Aug. 8, 2026 Daily
XJR · iShares Trust 0.26% 4,021 SH Aug. 8, 2026 Daily
IWO · iShares Trust 0.26% 312,826 SH Aug. 8, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.26% 52,359 SH Aug. 8, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.25% 36,861 SH Aug. 8, 2026 Daily
IJR · iShares Trust 0.23% 2,075,461 SH Aug. 8, 2026 Daily
VIOO · VANGUARD ADMIRAL FUNDS 0.23% 119,030 SH Aug. 8, 2026 Daily
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0.21% 10,711 NS April 30, 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0.21% 4,228 SH Aug. 8, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.21% 13,071 NS April 30, 2026 N-PORT
SMDX · Tidal Trust III 0.20% 2,228 NS April 30, 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0.20% 46,807 NS May 31, 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0.18% 1,290 NS April 30, 2026 N-PORT
DFAT · Dimensional ETF Trust 0.18% 217,961 NS April 30, 2026 N-PORT
SAA · ProShares Trust 0.18% 412 NS May 31, 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0.14% 29,761 NS April 30, 2026 N-PORT
GMOV · GMO ETF Trust 0.14% 1,078 NS May 31, 2026 N-PORT
IWM · iShares Trust 0.13% 875,500 SH Aug. 8, 2026 Daily
ISCG · iShares Trust 0.13% 10,563 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.13% 198,216 SH Aug. 8, 2026 Daily
FNDA · SCHWAB STRATEGIC TRUST 0.13% 98,138 NS May 31, 2026 N-PORT
RWJ · Invesco Exchange-Traded Fund Trust … 0.13% 19,006 SH Aug. 8, 2026 Daily
SMLF · iShares Trust 0.12% 41,596 SH Aug. 8, 2026 Daily
VFQY · VANGUARD WELLINGTON FUND 0.12% 4,599 SH Aug. 8, 2026 Daily
PKW · Invesco Exchange-Traded Fund Trust 0.12% 15,066 SH Aug. 8, 2026 Daily
VCR · VANGUARD WORLD FUND 0.12% 67,714 SH Aug. 8, 2026 Daily
RSSL · Global X Funds 0.12% 14,797 NS April 30, 2026 N-PORT
FYX · First Trust Exchange-Traded AlphaDE… 0.11% 12,017 NS April 30, 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0.11% 9,365 NS May 31, 2026 N-PORT
FDIS · FIDELITY COVINGTON TRUST 0.10% 15,550 NS April 30, 2026 N-PORT
ITWO · ProShares Trust 0.10% 1,606 NS May 31, 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.10% 5,421 SH Aug. 8, 2026 Daily
DFAS · Dimensional ETF Trust 0.09% 111,249 NS April 30, 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0.09% 470,701 SH Aug. 8, 2026 Daily
SCHA · SCHWAB STRATEGIC TRUST 0.09% 165,865 NS May 31, 2026 N-PORT
ESML · iShares Trust 0.07% 16,803 SH Aug. 8, 2026 Daily
FAD · First Trust Exchange-Traded AlphaDE… 0.07% 2,779 NS April 30, 2026 N-PORT
ISCB · iShares Trust 0.06% 1,479 SH Aug. 8, 2026 Daily